Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Wanjia Group HoldingsHKSE:00401 36 Days Inventory is 38.17 as of Mar. 2026, which is 11% below its 10-year median of 42.67. GuruFocus rates HKSE:00401 with a GF Score™ of 36/100 and a GF Value™ of HK$0.06 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 117 Medical Distribution companies, Wanjia Group Holdings ranks better than 67.52% on this metric.
The historical rank and industry rank for Wanjia Group Holdings's Days Inventory or its related term are showing as below:
HKSE:00401'
s Days Inventory Range Over the Past 10 Years
Min: 29.77 Med: 42.67 Max: 165.73
Current: 36.04
During the past 13 years, Wanjia Group Holdings's highest Days Inventory was 165.73. The lowest was 29.77. And the median was 42.67.
HKSE:00401's Days Inventory is ranked better than 67.52% of 117
companies
in the Medical Distribution industry
Industry Median: 55.31
vs HKSE:00401: 36.04
Inventory Turnover measures how fast the company turns over its inventory within a year.
Wanjia Group Holdings's Inventory Turnover for the
six
months ended in Mar. 2026 was 4.78.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Wanjia Group Holdings's Inventory-to-Revenue for the
six
months ended in Mar. 2026 was 0.16.
Wanjia Group Holdings (HKSE:00401) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Wanjia Group Holdings's Inventory Turnover for the
six
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Wanjia Group Holdings's Inventory to Revenue for the
six
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Wanjia Group Holdings Days Inventory Related Terms
Wanjia Group Holdings Days Inventory Historical Data
* Premium members only.
The historical data trend for Wanjia Group Holdings's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:00401 vs MCK, COR, CAH: Days Inventory Comparison
For the Medical Distribution subindustry, Wanjia Group Holdings's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Wanjia Group Holdings Days Inventory vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Wanjia Group Holdings's Days Inventory distribution charts can be found below:
* The bar in red indicates where Wanjia Group Holdings's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Wanjia Group Holdings (HKSE:00401) has a Days Inventory of 38.17 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Wanjia Group Holdings and its competitors. This is 11% below median its historical median of 42.67. Over the past decade, Wanjia Group Holdings' Days Inventory has ranged from 29.77 to 165.73. According to the industry distribution chart, Wanjia Group Holdings ranks #38 out of 117 companies in the Medical Distribution industry, placing it in the top 32.5%.
Is Wanjia Group Holdings' Days Inventory too high?
Wanjia Group Holdings' current Days Inventory of 38.17 is 11% below median its 10-year median of 42.67. Over the past 10 years, this metric has ranged from a low of 29.77 to a high of 165.73. The Medical Distribution industry median Days Inventory is 55.31. Wanjia Group Holdings' value of 38.17 is 31% below this industry median. Based on the distribution chart, Wanjia Group Holdings ranks #38 out of 117 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Wanjia Group Holdings has a GF Score™ of 36/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Wanjia Group Holdings' Days Inventory compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Wanjia Group Holdings ranks #38 out of 117 companies for Days Inventory. This puts Wanjia Group Holdings in the upper half of its industry. The industry median Days Inventory is 55.31. Wanjia Group Holdings' value of 38.17 is 31% below this benchmark. Historically, Wanjia Group Holdings' own Days Inventory has ranged from 29.77 to 165.73 over the past decade. While the company's 10-year median is 42.67 vs. the industry median of 55.31, Wanjia Group Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Distribution company?
The median Days Inventory among Medical Distribution companies is 55.31, based on 117 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Wanjia Group Holdings's current Days Inventory of 38.17 is 31% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Wanjia Group Holdings and its competitors. For the Medical Distribution industry, the median Days Inventory is 55.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Wanjia Group Holdings's current Days Inventory is 38.17, which is 11% below median its own 10-year median of 42.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wanjia Group Holdings stock overvalued right now?
Based on GuruFocus' analysis, Wanjia Group Holdings (HKSE:00401) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.06, compared to a current price of HK$0.13 — trading 116.7% above its estimated fair value. The current Days Inventory is 38.17, which is 11% below median its 10-year median of 42.67 and 31% below the Medical Distribution industry median of 55.31. Wanjia Group Holdings' overall GF Score™ is 36/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Wanjia Group Holdings (HKSE:00401), the current Days Inventory is 38.17 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Wanjia Group Holdings (HKSE:00401) Overvalued in 2026?
Based on GuruFocus' analysis, Wanjia Group Holdings stock appears to be overvalued.
The current stock price of HK$0.13 is trading 116.7% above its estimated GF Value™ of HK$0.06.
GuruFocus considers Wanjia Group Holdings to be Significantly Overvalued.
Key valuation signals for HKSE:00401:
Days Inventory: 38.17 (11% below median its 10-year median of 42.67)
GF Value™: HK$0.06 vs. price of HK$0.13 (116.7% above fair value)
Industry Position: 31% below the Medical Distribution median (#38 of 117)
No single metric tells the full story. See the HKSE:00401 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Wanjia Group Holdings Ltd is an investment holding company. Along with its subsidiaries, the company operates in principal activities of Pharmaceutical wholesale and distribution business, and Hemodialysis treatment and consultancy service business. The company generates key revenue from the Hemodialysis treatment and consultancy service business. Geographically, company operates in Hong Kong and China, having majority revenue generation from Mainland China.
36GF Score
Get the complete analysis for HKSE:00401
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:00401 has been successfully added to your 
